US Patent 7449479 Hepatitis C virus inhibitors
Patent 7449479 was granted and assigned to Bristol-Myers Squibb on November, 2008 by the United States Patent and Trademark Office.
All edits
Edits on 15 Sep, 2023
Golden AI
Edits made to:
Article (+85 characters)
Article
Patent abstract
Hepatitis C virus inhibitors are disclosed having the general formula:
Edits on 25 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07449479 Hepatitis C virus inhibitors US Patent 7449479 Hepatitis C virus inhibitors
Infobox
Patent Number
0744947900
Patent Number
744947900
Edits on 20 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 23 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
074494790
Date of Patent
November 11, 2008
0Patent Application Number
112959140
Date Filed
December 7, 2005
0Official Website
Patent Primary Examiner
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
074494790
Date of Patent
November 11, 2008
0Patent Application Number
112959140
Date Filed
December 7, 2005
0Official Website
Patent Primary Examiner
Edits on 14 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 1 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07449479 Hepatitis C virus inhibitors
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07449479
Date of patent
November 11, 2008
Patent application number
11295914
Date Filed
December 7, 2005
Patent primary examiner
Find more entities like US Patent 7449479 Hepatitis C virus inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
